Literature DB >> 20428464

MicroRNA polymorphisms: a giant leap towards personalized medicine.

Prasun J Mishra.   

Abstract

"An individual's genetic inheritance of microRNA polymorphisms associated with disease progression, prognosis and treatment holds the key to create safer and more personalized drugs and can be a giant leap towards personalized medicine."

Entities:  

Year:  2009        PMID: 20428464      PMCID: PMC2860186          DOI: 10.2217/17410541.6.2.119

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  50 in total

1.  Short blocks from the noncoding parts of the human genome have instances within nearly all known genes and relate to biological processes.

Authors:  Isidore Rigoutsos; Tien Huynh; Kevin Miranda; Aristotelis Tsirigos; Alice McHardy; Daniel Platt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

4.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

Review 5.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.

Authors:  Prasun J Mishra; Pravin J Mishra; Debabrata Banerjee; Joseph R Bertino
Journal:  Cell Cycle       Date:  2008-01-28       Impact factor: 4.534

6.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

7.  Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.

Authors:  Zhibin Hu; Jie Liang; Zhanwei Wang; Tian Tian; Xiaoyi Zhou; Jiaping Chen; Ruifen Miao; Yan Wang; Xinru Wang; Hongbing Shen
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

8.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.

Authors:  Annika Brendle; Haixin Lei; Andreas Brandt; Robert Johansson; Kerstin Enquist; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Carcinogenesis       Date:  2008-06-10       Impact factor: 4.944

9.  REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.

Authors:  Christian Beetz; Rebecca Schüle; Tine Deconinck; Khanh-Nhat Tran-Viet; Hui Zhu; Berry P H Kremer; Suzanna G M Frints; Wendy A G van Zelst-Stams; Paula Byrne; Susanne Otto; Anders O H Nygren; Jonathan Baets; Katrien Smets; Berten Ceulemans; Bernard Dan; Narasimhan Nagan; Jan Kassubek; Sven Klimpe; Thomas Klopstock; Henning Stolze; Hubert J M Smeets; Constance T R M Schrander-Stumpel; Michael Hutchinson; Bart P van de Warrenburg; Corey Braastad; Thomas Deufel; Margaret Pericak-Vance; Ludger Schöls; Peter de Jonghe; Stephan Züchner
Journal:  Brain       Date:  2008-03-05       Impact factor: 13.501

10.  A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Tomoyuki Shibata; Mitsuo Nagasaka; Masakatsu Nakamura; Yoshio Kamiya; Hiroshi Fujita; Shin Hasegawa; Tamaki Takagi; Fang-Yu Wang; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-03-16       Impact factor: 3.487

View more
  10 in total

1.  Perspectives on personalized cancer care.

Authors:  Garrett M Dancika; Dan Theodorescu
Journal:  Urol Oncol       Date:  2012 Mar-Apr       Impact factor: 3.498

Review 2.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

3.  Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G.

Authors:  Xiaokun Bian; Yuanquan Si; Min Zhang; Ran Wei; Xiaomin Yang; Hao Ren; Guixi Zheng; Chuanxin Wang; Yi Zhang
Journal:  Tumour Biol       Date:  2015-10-14

4.  Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.

Authors:  Prasun J Mishra
Journal:  Expert Rev Mol Diagn       Date:  2014-11       Impact factor: 5.225

5.  MicroRNA reexpression as differentiation therapy in cancer.

Authors:  Prasun J Mishra; Glenn Merlino
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins.

Authors:  Prasun J Mishra
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

7.  Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis.

Authors:  Nalini Raghavachari; Poching Liu; Jennifer J Barb; Yanqin Yang; Richard Wang; Quang Tri Nguyen; Peter J Munson
Journal:  Exp Hematol       Date:  2013-10-16       Impact factor: 3.084

8.  MicroRNAs as promising biomarkers in cancer diagnostics.

Authors:  Prasun J Mishra
Journal:  Biomark Res       Date:  2014-10-22

9.  MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Authors:  Prasun J Mishra; Bo Song; Pravin J Mishra; Yuan Wang; Rita Humeniuk; Debabrata Banerjee; Glenn Merlino; Jingfang Ju; Joseph R Bertino
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

Review 10.  Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.

Authors:  Nicoletta Nuzziello; Loredana Ciaccia; Maria Liguori
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.